Antoine Andremont

14.4k total citations · 1 hit paper
226 papers, 9.9k citations indexed

About

Antoine Andremont is a scholar working on Molecular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Antoine Andremont has authored 226 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Molecular Medicine, 75 papers in Infectious Diseases and 60 papers in Molecular Biology. Recurrent topics in Antoine Andremont's work include Antibiotic Resistance in Bacteria (116 papers), Bacterial Identification and Susceptibility Testing (39 papers) and Antibiotics Pharmacokinetics and Efficacy (34 papers). Antoine Andremont is often cited by papers focused on Antibiotic Resistance in Bacteria (116 papers), Bacterial Identification and Susceptibility Testing (39 papers) and Antibiotics Pharmacokinetics and Efficacy (34 papers). Antoine Andremont collaborates with scholars based in France, United States and Switzerland. Antoine Andremont's co-authors include Laurence Armand-Lefèvre, Raymond Ruimy, Paul‐Louis Woerther, Élisabeth Chachaty, Jean‐Christophe Lucet, Charles Burdet, C Tancrède, Patrick Couvreur, Patrice Courvalin and Étienne Ruppé and has published in prestigious journals such as The Lancet, Nature Medicine and PLoS ONE.

In The Last Decade

Antoine Andremont

221 papers receiving 9.5k citations

Hit Papers

Trends in Human Fecal Car... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antoine Andremont France 56 3.5k 3.4k 2.7k 2.5k 1.6k 226 9.9k
Clinical 12 3.2k 0.9× 3.2k 0.9× 2.5k 0.9× 2.5k 1.0× 1.5k 1.0× 23 11.0k
Stefania Stefani Italy 47 3.1k 0.9× 2.8k 0.8× 3.2k 1.2× 1.8k 0.7× 1.5k 1.0× 363 10.7k
Michael R. Mulvey Canada 49 3.0k 0.9× 3.7k 1.1× 2.1k 0.8× 1.8k 0.7× 1.3k 0.9× 217 8.6k
Ellen E. Stobberingh Netherlands 53 3.5k 1.0× 2.4k 0.7× 4.6k 1.7× 3.0k 1.2× 1.6k 1.0× 255 13.7k
Arnfinn Sundsfjord Norway 49 2.3k 0.7× 4.1k 1.2× 1.8k 0.7× 1.4k 0.6× 1.5k 0.9× 156 8.4k
Jan Kluytmans Netherlands 42 3.1k 0.9× 2.4k 0.7× 1.8k 0.7× 2.1k 0.8× 1.5k 1.0× 199 8.5k
Hui Wang China 54 2.7k 0.8× 3.5k 1.0× 2.7k 1.0× 2.7k 1.1× 1.1k 0.7× 334 10.2k
Pentti Huovinen Finland 50 2.8k 0.8× 2.8k 0.8× 1.9k 0.7× 3.1k 1.2× 853 0.5× 205 10.5k
Deirdre L. Church Canada 48 2.5k 0.7× 2.6k 0.8× 1.6k 0.6× 3.7k 1.5× 1.8k 1.2× 210 9.3k
Alan P. Johnson United Kingdom 48 2.5k 0.7× 2.5k 0.7× 1.1k 0.4× 2.5k 1.0× 1.6k 1.0× 231 8.2k

Countries citing papers authored by Antoine Andremont

Since Specialization
Citations

This map shows the geographic impact of Antoine Andremont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoine Andremont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoine Andremont more than expected).

Fields of papers citing papers by Antoine Andremont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoine Andremont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoine Andremont. The network helps show where Antoine Andremont may publish in the future.

Co-authorship network of co-authors of Antoine Andremont

This figure shows the co-authorship network connecting the top 25 collaborators of Antoine Andremont. A scholar is included among the top collaborators of Antoine Andremont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoine Andremont. Antoine Andremont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burdet, Charles, Thu Thuy Nguyen, Perrine Hugon, et al.. (2018). Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection. Antimicrobial Agents and Chemotherapy. 62(10). 21 indexed citations
2.
Diallo, Souleymane, Niels Olsen Saraiva Câmara, Ibréhima Guindo, et al.. (2017). Prevalence of extended-spectrum beta-lactamase phenotypes in enterobacteria isolated from blood cultures of patients at admission to the University Hospital of Bamako. Médecine et Santé Tropicales. 27(2). 170–175. 3 indexed citations
3.
Lucet, Jean‐Christophe, Anne Perozziello, Camille Pelat, et al.. (2017). Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis. BMJ Open. 7(11). e017402–e017402. 19 indexed citations
4.
Gosalbes, María José, Jorge F. Vázquez‐Castellanos, Cécile Angebault, et al.. (2015). Carriage of Enterobacteria Producing Extended-Spectrum β-Lactamases and Composition of the Gut Microbiota in an Amerindian Community. Antimicrobial Agents and Chemotherapy. 60(1). 507–514. 35 indexed citations
5.
Woerther, Paul‐Louis, Charles Burdet, Élisabeth Chachaty, & Antoine Andremont. (2013). Trends in Human Fecal Carriage of Extended-Spectrum β-Lactamases in the Community: Toward the Globalization of CTX-M. Clinical Microbiology Reviews. 26(4). 744–758. 497 indexed citations breakdown →
6.
Huttner, Benedikt, Thomas Haustein, Ilker Uçkay, et al.. (2013). Decolonization of intestinal carriage of extended-spectrum  -lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. Journal of Antimicrobial Chemotherapy. 68(10). 2375–82. 73 indexed citations
7.
Angebault, Cécile, Félix Djossou, Sophie Abélanet, et al.. (2013). Candida albicans Is Not Always the Preferential Yeast Colonizing Humans: A Study in Wayampi Amerindians. The Journal of Infectious Diseases. 208(10). 1705–1716. 73 indexed citations
9.
Barbier, François, David Lebeaux, David Hernández, et al.. (2010). High prevalence of the arginine catabolic mobile element in carriage isolates of methicillin-resistant Staphylococcus epidermidis. Journal of Antimicrobial Chemotherapy. 66(1). 29–36. 78 indexed citations
10.
Skurnik, David, Claire Bernède, Arnaud Le Menach, et al.. (2009). Integrons and Antibiotic Resistance in Phylogenetic Group B2 Escherichia coli. Microbial Drug Resistance. 15(3). 173–178. 12 indexed citations
11.
Lasocki, Sigismond, David Skurnik, Claudette Muller‐Serieys, et al.. (2009). Rapid Adaptation of Antibiotic Therapy for Community-Acquired Peritonitis Using Direct Cultures on Antibiotic Agar Plates: Pilot Study. Surgical Infections. 10(4). 333–338. 1 indexed citations
12.
Nguyen, Minh, et al.. (2009). Escherichia colias Reservoir for Macrolide Resistance Genes. Emerging infectious diseases. 15(10). 1648–1650. 149 indexed citations
13.
Andremont, Antoine, Robert Cohen, & H Drugeon. (2004). Comment définir le potentiel de sélection de la résistance bactérienne par les antibiotiques?. Médecine et Maladies Infectieuses. 34. S109–S111. 1 indexed citations
14.
Baddour, Larry M., Victor L. Yu, Keith P. Klugman, et al.. (2004). Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia. American Journal of Respiratory and Critical Care Medicine. 170(4). 440–444. 301 indexed citations
15.
Cabrol, S, et al.. (2003). Transcription of Quorum-Sensing System Genes inClinical and Environmental Isolates of Pseudomonasaeruginosa. Journal of Bacteriology. 185(24). 7222–7230. 87 indexed citations
16.
Fattal, Elias, Sophie Pecquet, Patrick Couvreur, & Antoine Andremont. (2002). Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens. International Journal of Pharmaceutics. 242(1-2). 15–24. 37 indexed citations
17.
Andremont, Antoine, C. Brun‐Buisson, & Marc Struelens. (2001). Evaluating and predicting the ecologic impact of antibiotics. Clinical Microbiology and Infection. 7. 1–6. 16 indexed citations
18.
Andremont, Antoine, et al.. (2000). Physiopathologie des pneumopathies aiguës communautaires : le modèle des pneumonies à pneumocoque. 5(10). 807–814. 1 indexed citations
19.
Kunesch, Gerhard, et al.. (1998). Synthesis and In Vitro Antibacterial Activity of Catechol-spiramycin Conjugates.. The Journal of Antibiotics. 51(8). 786–794. 11 indexed citations
20.
Cordonnier, Charlotte, Guy Leverger, Benoı̂t Schlemmer, et al.. (1994). [Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].. PubMed. 36(4). 289–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026